Cathie Wood's position in Beam Therapeutics is currently worth $372 Million. That's 2.57% of their equity portfolio (15th largest holding). The investor owns 12.04% of the outstanding Beam Therapeutics stock. Cathie Wood started to build up the position in Beam Therapeutics in Q4 2020 and continued to invest until Q2 2022. Since then they sold 579 Thousand shares. The investor's estimated purchase price is $664 Million, resulting in a loss of 44%.